the present data demonstrate that combination of the synthetic progestin mpa and the inhibitor of prolactin secrection cb-154 exerts maximal inhibitory effects on the growth of the dmba-induced mammary tumor , the most widely used in vivo model of human breast cancer .
C0006141
mammary
C0006142
of